These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11126662)

  • 21. [First scientific conference on chronic fatigue syndrome and fibromyalgia, Lyon, January 25, 2002].
    Veyssier-Belot C
    Rev Med Interne; 2002 Jul; 23(7):577-80. PubMed ID: 12162212
    [No Abstract]   [Full Text] [Related]  

  • 22. Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: a review of case-control studies.
    Martínez-Martínez LA; Mora T; Vargas A; Fuentes-Iniestra M; Martínez-Lavín M
    J Clin Rheumatol; 2014 Apr; 20(3):146-50. PubMed ID: 24662556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic fatigue syndrome (CFS): Suggestions for a nutritional treatment in the therapeutic approach.
    Bjørklund G; Dadar M; Pen JJ; Chirumbolo S; Aaseth J
    Biomed Pharmacother; 2019 Jan; 109():1000-1007. PubMed ID: 30551349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chronic fatigue immune dysfunction syndrome].
    Uchida A
    Nihon Rinsho; 1992 Nov; 50(11):2625-9. PubMed ID: 1287238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic fatigue syndrome--a controlled cross sectional study.
    Rasmussen AK; Nielsen H; Andersen V; Barington T; Bendtzen K; Hansen MB; Nielsen L; Pedersen BK; Wiik A
    J Rheumatol; 1994 Aug; 21(8):1527-31. PubMed ID: 7983659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive behavioral therapy and fasting therapy for a patient with chronic fatigue syndrome.
    Masuda A; Nakayama T; Yamanaka T; Hatsutanmaru K; Tei C
    Intern Med; 2001 Nov; 40(11):1158-61. PubMed ID: 11757776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic fatigue syndrome: characteristics and possible causes for its pathogenesis.
    Bassi N; Amital D; Amital H; Doria A; Shoenfeld Y
    Isr Med Assoc J; 2008 Jan; 10(1):79-82. PubMed ID: 18300582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allostatic overload in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Arroll MA
    Med Hypotheses; 2013 Sep; 81(3):506-8. PubMed ID: 23850395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for the presence of immune dysfunction in chronic fatigue syndrome.
    Natelson BH; Haghighi MH; Ponzio NM
    Clin Diagn Lab Immunol; 2002 Jul; 9(4):747-52. PubMed ID: 12093668
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunodysregulation and chronic fatigue syndrome.
    Kundu SK; Ahronheim GA; Menezes J
    Can Dis Wkly Rep; 1991 Jan; 17 Suppl 1E():49-50. PubMed ID: 1669353
    [No Abstract]   [Full Text] [Related]  

  • 31. Antinuclear antibodies in children with chronic nonspecific complaints.
    Itoh Y; Hamada H; Imai T; Seki T; Igarashi T; Yuge K; Fukunaga Y; Yamamoto M
    Autoimmunity; 1997; 25(4):243-50. PubMed ID: 9344332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The inflammatory hypothesis of mood spectrum broadened to fibromyalgia and chronic fatigue syndrome.
    Dell'Osso L; Bazzichi L; Baroni S; Falaschi V; Conversano C; Carmassi C; Marazziti D
    Clin Exp Rheumatol; 2015; 33(1 Suppl 88):S109-16. PubMed ID: 25786052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibromyalgia and chronic fatigue syndrome in children.
    Itoh Y; Shigemori T; Igarashi T; Fukunaga Y
    Pediatr Int; 2012 Apr; 54(2):266-71. PubMed ID: 22115414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibromyalgia, chronic fatigue syndrome, and Addison disease.
    Baschetti R
    Arch Intern Med; 1999 Nov; 159(20):2481; author reply 2482-3. PubMed ID: 10665898
    [No Abstract]   [Full Text] [Related]  

  • 35. Decreased nitric oxide-mediated natural killer cell activation in chronic fatigue syndrome.
    Ogawa M; Nishiura T; Yoshimura M; Horikawa Y; Yoshida H; Okajima Y; Matsumura I; Ishikawa J; Nakao H; Tomiyama Y; Kanayama Y; Kanakura Y; Matsuzawa Y
    Eur J Clin Invest; 1998 Nov; 28(11):937-43. PubMed ID: 9824439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoantibodies to a 68/48 kDa protein in chronic fatigue syndrome and primary fibromyalgia: a possible marker for hypersomnia and cognitive disorders.
    Nishikai M; Tomomatsu S; Hankins RW; Takagi S; Miyachi K; Kosaka S; Akiya K
    Rheumatology (Oxford); 2001 Jul; 40(7):806-10. PubMed ID: 11477286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Huth TK; Staines D; Marshall-Gradisnik S
    J Transl Med; 2016 Apr; 14():97. PubMed ID: 27098723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in natural killer cell phenotype in patients with post-viral fatigue syndrome.
    Morrison LJ; Behan WH; Behan PO
    Clin Exp Immunol; 1991 Mar; 83(3):441-6. PubMed ID: 1706238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoglobulin subclass abnormalities in patients with chronic fatigue syndrome.
    Wakefield D; Lloyd A; Brockman A
    Pediatr Infect Dis J; 1990 Aug; 9(8 Suppl):S50-3. PubMed ID: 2216608
    [No Abstract]   [Full Text] [Related]  

  • 40. Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome.
    Meeus M; Nijs J
    Clin Rheumatol; 2007 Apr; 26(4):465-73. PubMed ID: 17115100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.